Multiple sclerosis: modulation of toll-like receptor (TLR) expression by interferon-β includes upregulation of TLR7 in plasmacytoid dendritic cells.
Interferon-β is an established treatment for patients with multiple sclerosis (MS) but its mechanisms of action are not well understood. Viral infections are a known trigger of MS relapses. Toll-like receptors (TLRs) are key components of the innate immune system, which sense conserved structures of...
Guardado en:
| Autores principales: | , , , , , , , , , , , , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
Public Library of Science (PLoS)
2013
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/eb1df074a4e941838c7b5bfc2b300752 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| id |
oai:doaj.org-article:eb1df074a4e941838c7b5bfc2b300752 |
|---|---|
| record_format |
dspace |
| spelling |
oai:doaj.org-article:eb1df074a4e941838c7b5bfc2b3007522021-11-18T09:00:17ZMultiple sclerosis: modulation of toll-like receptor (TLR) expression by interferon-β includes upregulation of TLR7 in plasmacytoid dendritic cells.1932-620310.1371/journal.pone.0070626https://doaj.org/article/eb1df074a4e941838c7b5bfc2b3007522013-01-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/23950974/?tool=EBIhttps://doaj.org/toc/1932-6203Interferon-β is an established treatment for patients with multiple sclerosis (MS) but its mechanisms of action are not well understood. Viral infections are a known trigger of MS relapses. Toll-like receptors (TLRs) are key components of the innate immune system, which sense conserved structures of viruses and other pathogens. Effects of interferon-β on mRNA levels of all known human TLRs (TLR1-10) and the TLR adaptor molecule MyD88 were analyzed in peripheral blood mononuclear cells (PBMCs) of healthy donors by quantitative real-time PCR and by transcriptome analysis in PBMCs of 25 interferon-β-treated patients with relapsing-remitting MS. Regulation of TLR protein expression by interferon-β was investigated by flow cytometry of leukocyte subsets of healthy subjects and of untreated, interferon-β-, or glatiramer acetate-treated patients with MS. Interferon-β specifically upregulated mRNA expression of TLR3, TLR7, and MyD88 and downregulated TLR9 mRNA in PBMCs of healthy donors as well as in PBMCs of patients with MS. Plasmacytoid dendritic cells (pDCs) were identified as the major cell type responding to interferon-β with increased expression of TLR7 and MyD88 protein. In line with this, expression of TLR7 protein was increased in pDCs of interferon-β-treated, but not untreated or glatiramer acetate-treated patients with MS. Interferon-β-induced upregulation of TLR7 in pDCs is of functional relevance since pre-treatment of PBMCs with interferon-β resulted in a strongly increased production of interferon-α upon stimulation with the TLR7 agonist loxoribine. Flow cytometry confirmed pDCs as the cellular source of interferon-α production induced by activation of TLR7. Thus, upregulation of TLR7 in pDCs and a consequently increased activation of pDCs by TLR7 ligands represents a novel immunoregulatory mechanism of interferon-β. We hypothesize that this mechanism could contribute to a reduction of virus-triggered relapses in patients with MS.Katja DerkowJakob M J BauerMichael HeckerBrigitte K PaapMadhan ThamilarasanDirk KoczanEckart SchottKatrin DeuschleJudith Bellmann-StroblFriedemann PaulUwe K ZettlKlemens RuprechtSeija LehnardtPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 8, Iss 8, p e70626 (2013) |
| institution |
DOAJ |
| collection |
DOAJ |
| language |
EN |
| topic |
Medicine R Science Q |
| spellingShingle |
Medicine R Science Q Katja Derkow Jakob M J Bauer Michael Hecker Brigitte K Paap Madhan Thamilarasan Dirk Koczan Eckart Schott Katrin Deuschle Judith Bellmann-Strobl Friedemann Paul Uwe K Zettl Klemens Ruprecht Seija Lehnardt Multiple sclerosis: modulation of toll-like receptor (TLR) expression by interferon-β includes upregulation of TLR7 in plasmacytoid dendritic cells. |
| description |
Interferon-β is an established treatment for patients with multiple sclerosis (MS) but its mechanisms of action are not well understood. Viral infections are a known trigger of MS relapses. Toll-like receptors (TLRs) are key components of the innate immune system, which sense conserved structures of viruses and other pathogens. Effects of interferon-β on mRNA levels of all known human TLRs (TLR1-10) and the TLR adaptor molecule MyD88 were analyzed in peripheral blood mononuclear cells (PBMCs) of healthy donors by quantitative real-time PCR and by transcriptome analysis in PBMCs of 25 interferon-β-treated patients with relapsing-remitting MS. Regulation of TLR protein expression by interferon-β was investigated by flow cytometry of leukocyte subsets of healthy subjects and of untreated, interferon-β-, or glatiramer acetate-treated patients with MS. Interferon-β specifically upregulated mRNA expression of TLR3, TLR7, and MyD88 and downregulated TLR9 mRNA in PBMCs of healthy donors as well as in PBMCs of patients with MS. Plasmacytoid dendritic cells (pDCs) were identified as the major cell type responding to interferon-β with increased expression of TLR7 and MyD88 protein. In line with this, expression of TLR7 protein was increased in pDCs of interferon-β-treated, but not untreated or glatiramer acetate-treated patients with MS. Interferon-β-induced upregulation of TLR7 in pDCs is of functional relevance since pre-treatment of PBMCs with interferon-β resulted in a strongly increased production of interferon-α upon stimulation with the TLR7 agonist loxoribine. Flow cytometry confirmed pDCs as the cellular source of interferon-α production induced by activation of TLR7. Thus, upregulation of TLR7 in pDCs and a consequently increased activation of pDCs by TLR7 ligands represents a novel immunoregulatory mechanism of interferon-β. We hypothesize that this mechanism could contribute to a reduction of virus-triggered relapses in patients with MS. |
| format |
article |
| author |
Katja Derkow Jakob M J Bauer Michael Hecker Brigitte K Paap Madhan Thamilarasan Dirk Koczan Eckart Schott Katrin Deuschle Judith Bellmann-Strobl Friedemann Paul Uwe K Zettl Klemens Ruprecht Seija Lehnardt |
| author_facet |
Katja Derkow Jakob M J Bauer Michael Hecker Brigitte K Paap Madhan Thamilarasan Dirk Koczan Eckart Schott Katrin Deuschle Judith Bellmann-Strobl Friedemann Paul Uwe K Zettl Klemens Ruprecht Seija Lehnardt |
| author_sort |
Katja Derkow |
| title |
Multiple sclerosis: modulation of toll-like receptor (TLR) expression by interferon-β includes upregulation of TLR7 in plasmacytoid dendritic cells. |
| title_short |
Multiple sclerosis: modulation of toll-like receptor (TLR) expression by interferon-β includes upregulation of TLR7 in plasmacytoid dendritic cells. |
| title_full |
Multiple sclerosis: modulation of toll-like receptor (TLR) expression by interferon-β includes upregulation of TLR7 in plasmacytoid dendritic cells. |
| title_fullStr |
Multiple sclerosis: modulation of toll-like receptor (TLR) expression by interferon-β includes upregulation of TLR7 in plasmacytoid dendritic cells. |
| title_full_unstemmed |
Multiple sclerosis: modulation of toll-like receptor (TLR) expression by interferon-β includes upregulation of TLR7 in plasmacytoid dendritic cells. |
| title_sort |
multiple sclerosis: modulation of toll-like receptor (tlr) expression by interferon-β includes upregulation of tlr7 in plasmacytoid dendritic cells. |
| publisher |
Public Library of Science (PLoS) |
| publishDate |
2013 |
| url |
https://doaj.org/article/eb1df074a4e941838c7b5bfc2b300752 |
| work_keys_str_mv |
AT katjaderkow multiplesclerosismodulationoftolllikereceptortlrexpressionbyinterferonbincludesupregulationoftlr7inplasmacytoiddendriticcells AT jakobmjbauer multiplesclerosismodulationoftolllikereceptortlrexpressionbyinterferonbincludesupregulationoftlr7inplasmacytoiddendriticcells AT michaelhecker multiplesclerosismodulationoftolllikereceptortlrexpressionbyinterferonbincludesupregulationoftlr7inplasmacytoiddendriticcells AT brigittekpaap multiplesclerosismodulationoftolllikereceptortlrexpressionbyinterferonbincludesupregulationoftlr7inplasmacytoiddendriticcells AT madhanthamilarasan multiplesclerosismodulationoftolllikereceptortlrexpressionbyinterferonbincludesupregulationoftlr7inplasmacytoiddendriticcells AT dirkkoczan multiplesclerosismodulationoftolllikereceptortlrexpressionbyinterferonbincludesupregulationoftlr7inplasmacytoiddendriticcells AT eckartschott multiplesclerosismodulationoftolllikereceptortlrexpressionbyinterferonbincludesupregulationoftlr7inplasmacytoiddendriticcells AT katrindeuschle multiplesclerosismodulationoftolllikereceptortlrexpressionbyinterferonbincludesupregulationoftlr7inplasmacytoiddendriticcells AT judithbellmannstrobl multiplesclerosismodulationoftolllikereceptortlrexpressionbyinterferonbincludesupregulationoftlr7inplasmacytoiddendriticcells AT friedemannpaul multiplesclerosismodulationoftolllikereceptortlrexpressionbyinterferonbincludesupregulationoftlr7inplasmacytoiddendriticcells AT uwekzettl multiplesclerosismodulationoftolllikereceptortlrexpressionbyinterferonbincludesupregulationoftlr7inplasmacytoiddendriticcells AT klemensruprecht multiplesclerosismodulationoftolllikereceptortlrexpressionbyinterferonbincludesupregulationoftlr7inplasmacytoiddendriticcells AT seijalehnardt multiplesclerosismodulationoftolllikereceptortlrexpressionbyinterferonbincludesupregulationoftlr7inplasmacytoiddendriticcells |
| _version_ |
1718421057508999168 |